WO1995028124A3 - An adjunctive polymer system for use with medical device - Google Patents

An adjunctive polymer system for use with medical device Download PDF

Info

Publication number
WO1995028124A3
WO1995028124A3 PCT/US1995/003259 US9503259W WO9528124A3 WO 1995028124 A3 WO1995028124 A3 WO 1995028124A3 US 9503259 W US9503259 W US 9503259W WO 9528124 A3 WO9528124 A3 WO 9528124A3
Authority
WO
WIPO (PCT)
Prior art keywords
polymer system
adjunctive polymer
medical device
adjunctive
solid matrix
Prior art date
Application number
PCT/US1995/003259
Other languages
French (fr)
Other versions
WO1995028124A2 (en
Inventor
Richard L Dunn
Gerald L Yewey
Jeffrey L Southland
John E Urheim
Original Assignee
Atrix Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atrix Lab Inc filed Critical Atrix Lab Inc
Priority to CA002187355A priority Critical patent/CA2187355C/en
Priority to DE69530919T priority patent/DE69530919T2/en
Priority to EP95913716A priority patent/EP0754064B1/en
Priority to AT95913716T priority patent/ATE241394T1/en
Priority to JP7526962A priority patent/JPH09511666A/en
Priority to AU19999/95A priority patent/AU1999995A/en
Publication of WO1995028124A2 publication Critical patent/WO1995028124A2/en
Publication of WO1995028124A3 publication Critical patent/WO1995028124A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/62—Compostable, hydrosoluble or hydrodegradable materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06—At least partially resorbable materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/009—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S528/00—Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S528/905—Polymer prepared from isocyanate reactant has adhesive property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S602/00—Surgery: splint, brace, or bandage
    • Y10S602/904—Film-forming bandage material

Abstract

A medical device which is a surgically implantable device coated with an adjunctive polymer system. The adjunctive polymer system forms a solid matrix when introduced into a human or animal body. The adjunctive polymer system can contain a drug or a medicament which is released over time from the solid matrix. The adjunctive polymer system contacts body tissue into which the surgically implantable device is implanted.
PCT/US1995/003259 1994-04-08 1995-03-15 An adjunctive polymer system for use with medical device WO1995028124A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA002187355A CA2187355C (en) 1994-04-08 1995-03-15 An adjunctive polymer system for use with medical device
DE69530919T DE69530919T2 (en) 1994-04-08 1995-03-15 ASSOCIATED POLYMER SYSTEM FOR USE WITH A MEDICAL DEVICE
EP95913716A EP0754064B1 (en) 1994-04-08 1995-03-15 An adjunctive polymer system for use with medical device
AT95913716T ATE241394T1 (en) 1994-04-08 1995-03-15 ASSOCIATED POLYMER SYSTEM FOR USE WITH A MEDICAL DEVICE
JP7526962A JPH09511666A (en) 1994-04-08 1995-03-15 Ancillary polymer systems for use in medical devices
AU19999/95A AU1999995A (en) 1994-04-08 1995-03-15 An adjunctive polymer system for use with medical device

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22600694A 1994-04-08 1994-04-08
US08/226,006 1994-04-08

Publications (2)

Publication Number Publication Date
WO1995028124A2 WO1995028124A2 (en) 1995-10-26
WO1995028124A3 true WO1995028124A3 (en) 1996-02-15

Family

ID=22847171

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1995/003259 WO1995028124A2 (en) 1994-04-08 1995-03-15 An adjunctive polymer system for use with medical device

Country Status (8)

Country Link
US (2) US5707647A (en)
EP (1) EP0754064B1 (en)
JP (1) JPH09511666A (en)
AT (1) ATE241394T1 (en)
AU (1) AU1999995A (en)
CA (1) CA2187355C (en)
DE (1) DE69530919T2 (en)
WO (1) WO1995028124A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8870954B2 (en) 2008-09-09 2014-10-28 Biomimetic Therapeutics, Llc Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
US9468707B2 (en) 2007-06-29 2016-10-18 Abbott Cardiovascular Systems Inc. Biodegradable triblock copolymers for implantable devices
US9539332B2 (en) 2004-08-05 2017-01-10 Abbott Cardiovascular Systems Inc. Plasticizers for coating compositions
US9545377B2 (en) 2004-10-14 2017-01-17 Biomimetic Therapeutics, Llc Platelet-derived growth factor compositions and methods of use thereof

Families Citing this family (189)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309669B1 (en) * 1984-03-16 2001-10-30 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US6132765A (en) * 1996-04-12 2000-10-17 Uroteq Inc. Drug delivery via therapeutic hydrogels
WO1997038648A1 (en) * 1996-04-16 1997-10-23 Implemed, Inc. Iontophoretic material
US6110155A (en) * 1996-04-30 2000-08-29 Medtronic, Inc. Anti-inflammatory-agent-loaded catheter and method for preventing tissue fibrosis
US5916585A (en) * 1996-06-03 1999-06-29 Gore Enterprise Holdings, Inc. Materials and method for the immobilization of bioactive species onto biodegradable polymers
DK0959873T3 (en) * 1996-12-20 2006-07-03 Alza Corp Gel composition and methods
US6042534A (en) * 1997-02-13 2000-03-28 Scimed Life Systems, Inc. Stabilization sling for use in minimally invasive pelvic surgery
AU8530498A (en) 1997-06-05 1998-12-21 Roland Bodmeier Multiphase system
DE19726412A1 (en) * 1997-06-21 1998-12-24 Merck Patent Gmbh Implant material with a carrier-drug combination
AUPO907697A0 (en) 1997-09-09 1997-10-02 Day, Robert Edward Chemical supplementation of bone
US6197036B1 (en) 1997-10-01 2001-03-06 Scimed Life Systems, Inc. Pelvic floor reconstruction
ES2359973T3 (en) 1998-03-19 2011-05-30 MERCK SHARP & DOHME CORP. LIQUID POLYMER COMPOSITIONS FOR THE CONTROLLED RELEASE OF BIOACTIVE SUBSTANCES.
EP1144323B1 (en) 1999-02-22 2007-07-25 DelSiTech Oy Biodegradable ceramic fibres from silica sols
EP2305324B1 (en) 1999-03-25 2014-09-17 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
US6554851B1 (en) 1999-05-07 2003-04-29 Scimed Life Systems, Inc. Methods of sealing an injection site
DE60031114T2 (en) * 1999-06-11 2007-05-03 Cytyc Corp., Marlborough LIQUID GEL FORMULATION FOR DETECTING MILK CHANNELS IN THE CHEST BEFORE SURGICAL ABLATION OF THE BREAST TISSUE
US6423818B1 (en) * 1999-07-30 2002-07-23 Takehisa Matsuda Coumarin endcapped absorbable polymers
US20030069545A1 (en) * 1999-12-06 2003-04-10 Arm Douglas M. Graft delivery syringe
EP1248596B1 (en) 2000-01-11 2007-03-07 Roland Bodmeier Implantation kit comprising a support phase and a solvent
US8460367B2 (en) 2000-03-15 2013-06-11 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
CN100506293C (en) 2000-03-15 2009-07-01 祥丰医疗有限公司 Coating that promotes endothelial Cell adherence
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US20030211974A1 (en) * 2000-03-21 2003-11-13 Brodbeck Kevin J. Gel composition and methods
EP1142596A1 (en) * 2000-04-03 2001-10-10 Universiteit Gent Compositions of crosslinkable prepolymers for use in therapeutically active biodegradable implants
FR2812551B1 (en) * 2000-08-07 2003-03-28 Virsol PHARMACEUTICAL FORM COMPRISING A METHYLIDENE MALONATE-BASED SUPPORT MATERIAL AND A CELL REGULATING FACTOR
EP1179353A1 (en) * 2000-08-11 2002-02-13 B. Braun Melsungen Ag Antithrombogenic implants with coating of polyphosphazenes and a pharmacologically active agent
US6689047B2 (en) 2000-11-15 2004-02-10 Scimed Life Systems, Inc. Treating urinary incontinence
US20020082222A1 (en) * 2000-11-30 2002-06-27 Shapira Nathan Andrew Treatments for neurogenetic disorders, impulse control disorder, and wound healing
JP2004525666A (en) * 2000-12-04 2004-08-26 グリュッスナー，ウヴェ，エミール，クリスティアン Method for producing partial or complete active substance coatings on and in implants and on-plants
US7700819B2 (en) * 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7763769B2 (en) * 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
US6991597B2 (en) 2001-03-09 2006-01-31 Boston Scientific Scimed, Inc. System for implanting an implant and method thereof
JP4181410B2 (en) * 2001-03-09 2008-11-12 ボストン サイエンティフィック リミテッド System and method for implanting an implant
US8033983B2 (en) * 2001-03-09 2011-10-11 Boston Scientific Scimed, Inc. Medical implant
US8187625B2 (en) 2001-03-12 2012-05-29 Boston Scientific Scimed, Inc. Cross-linked gelatin composition comprising a wetting agent
US6416745B1 (en) * 2001-05-03 2002-07-09 Block Drug Company, Inc. Dental composition for treating hypersensitive teeth
US6755781B2 (en) 2001-07-27 2004-06-29 Scimed Life Systems, Inc. Medical slings
AU2002316314B8 (en) * 2001-07-31 2008-04-03 Covidien Lp Bioabsorbable adhesive compounds and compositions
US6666817B2 (en) 2001-10-05 2003-12-23 Scimed Life Systems, Inc. Expandable surgical implants and methods of using them
KR100629380B1 (en) * 2001-11-30 2006-09-29 화이자 인코포레이티드 Controlled release polymeric compositions of bone growth promoting compounds
US20030105530A1 (en) * 2001-12-04 2003-06-05 Inion Ltd. Biodegradable implant and method for manufacturing one
US20030109820A1 (en) * 2001-12-07 2003-06-12 Gross T. Daniel Hemostatic agent delivery system
EP1344538A1 (en) 2002-03-14 2003-09-17 Degradable Solutions AG Porous biodegradable implant material and method for its fabrication
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) * 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7374678B2 (en) * 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
AU2003249642A1 (en) 2002-05-24 2003-12-12 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US20030225347A1 (en) * 2002-06-03 2003-12-04 Argenta Louis C. Directed tissue growth employing reduced pressure
WO2003105727A1 (en) 2002-06-12 2003-12-24 Scimed Life Systems, Inc. Medical slings
US20040001889A1 (en) * 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US20040039391A1 (en) * 2002-08-23 2004-02-26 Argenta Louis C. Bone treatment employing reduced pressure
US20040122434A1 (en) * 2002-08-23 2004-06-24 Argenta Louis C. Bone treatment employing reduced pressure
US7846141B2 (en) 2002-09-03 2010-12-07 Bluesky Medical Group Incorporated Reduced pressure treatment system
EP1549253A4 (en) * 2002-09-26 2010-11-03 Endovascular Devices Inc Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device
ES2327918T3 (en) * 2002-10-28 2009-11-05 Tyco Healthcare Group Lp BIOABSORBIBLE ADHESIVE COMPOUNDS.
GB0224986D0 (en) 2002-10-28 2002-12-04 Smith & Nephew Apparatus
US20050095267A1 (en) * 2002-12-04 2005-05-05 Todd Campbell Nanoparticle-based controlled release polymer coatings for medical implants
US7402133B2 (en) * 2002-12-17 2008-07-22 Boston Scientific Scimed, Inc. Spacer for sling delivery system
US7141054B2 (en) * 2003-02-03 2006-11-28 Biomet, Inc. Method and apparatus for intramedullary delivery of a material
US6893222B2 (en) * 2003-02-10 2005-05-17 United Technologies Corporation Turbine balancing
DE10305811A1 (en) * 2003-02-12 2004-08-26 Ethicon Gmbh Surgical implant, preferably in net form, comprises basic structure containing anabolic steroid and corticosteroid to accelerate healing and reduce scar contraction
US9445901B2 (en) * 2003-03-12 2016-09-20 Deger C. Tunc Prosthesis with sustained release analgesic
ES2279231T3 (en) 2003-05-09 2007-08-16 Tyco Healthcare Group Lp ANASTOMOTIC STAPLE WITH CAPILLARY TUBE THAT DISPENSES FLUIDS.
EP1628693A1 (en) * 2003-06-04 2006-03-01 Inion Ltd. Biodegradable implant and method for manufacturing one
US7361138B2 (en) 2003-07-31 2008-04-22 Scimed Life Systems, Inc. Bioabsorbable casing for surgical sling assembly
EP1671641B1 (en) 2003-09-09 2013-11-06 Two Cells Co., Ltd Remedy and therapeutic method for periodontal diseases and pulpal diseases
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050250737A1 (en) * 2003-11-12 2005-11-10 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
JP2005154477A (en) * 2003-11-20 2005-06-16 Tottori Univ Medical adhesive and medical coating agent using ultraviolet curing type chitosan derivative
AU2005209201B2 (en) 2004-01-20 2010-06-03 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
US7909805B2 (en) 2004-04-05 2011-03-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US8062272B2 (en) 2004-05-21 2011-11-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US10058642B2 (en) 2004-04-05 2018-08-28 Bluesky Medical Group Incorporated Reduced pressure treatment system
GB0409446D0 (en) 2004-04-28 2004-06-02 Smith & Nephew Apparatus
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US20050288481A1 (en) 2004-04-30 2005-12-29 Desnoyer Jessica R Design of poly(ester amides) for the control of agent-release from polymeric compositions
US8147865B2 (en) * 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
EP1740219B1 (en) 2004-04-30 2015-03-04 OrbusNeich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods of using same
US8163030B2 (en) 2004-05-06 2012-04-24 Degradable Solutions Ag Biocompatible bone implant compositions and methods for repairing a bone defect
EP1753478B1 (en) * 2004-05-27 2009-02-25 Medtronic, Inc. Medical device comprising a biologically active agent
US7863406B2 (en) * 2004-06-03 2011-01-04 Cornell Research Foundation, Inc. Unsaturated poly(ester-amide) biomaterials
US20110015367A1 (en) * 2004-06-03 2011-01-20 Cornell University Unsaturated poly(ester-amide) and poly(ether ester amide) biomaterials
JP2008505978A (en) * 2004-07-12 2008-02-28 アラーガン、インコーポレイテッド Ophthalmic composition and eye disease treatment method
US20060045902A1 (en) * 2004-09-01 2006-03-02 Serbousek Jon C Polymeric wrap for in vivo delivery of osteoinductive formulations
US20060153796A1 (en) * 2005-01-10 2006-07-13 Fitz Benjamin D Diisocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant
US8470954B2 (en) 2005-01-10 2013-06-25 Ethicon, Inc. Diisocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant
US7968668B2 (en) 2005-01-10 2011-06-28 Ethicon Inc. Diisocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant
US7728097B2 (en) * 2005-01-10 2010-06-01 Ethicon, Inc. Method of making a diisocyanate terminated macromer
US20070167617A1 (en) * 2006-01-17 2007-07-19 Fitz Benjamin D Method of making a diisocyanate terminated macromer
EP1846505B1 (en) 2005-02-09 2015-11-11 Covidien LP Synthetic sealants
CA2498623A1 (en) * 2005-02-18 2006-08-18 Qlt Inc. Treatment of onychomycosis
EP1864823B1 (en) * 2005-03-31 2014-08-27 Seiko Epson Corporation Inkjet recording method using a primer liquid
US20100100124A1 (en) * 2005-05-05 2010-04-22 Tyco Healthcare Group Lp Bioabsorbable surgical composition
US20100016888A1 (en) * 2005-05-05 2010-01-21 Allison Calabrese Surgical Gasket
US8044234B2 (en) * 2005-05-05 2011-10-25 Tyco Healthcare Group Lp Bioabsorbable surgical composition
US20090177226A1 (en) * 2005-05-05 2009-07-09 Jon Reinprecht Bioabsorbable Surgical Compositions
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
US8048297B2 (en) 2005-08-23 2011-11-01 Biomet Biologics, Llc Method and apparatus for collecting biological materials
US7771590B2 (en) * 2005-08-23 2010-08-10 Biomet Manufacturing Corp. Method and apparatus for collecting biological materials
AU2006321914B2 (en) * 2005-12-06 2012-01-19 Covidien Lp Bioabsorbable compounds and compositions containing them
EP1968617A4 (en) * 2005-12-06 2012-05-02 Tyco Healthcare Biocompatible tissue sealants and adhesives
JP5333911B2 (en) * 2005-12-06 2013-11-06 コヴィディエン リミテッド パートナーシップ Biocompatible surgical composition
JP2009518519A (en) * 2005-12-06 2009-05-07 タイコ ヘルスケア グループ リミテッド パートナーシップ Carbodiimide crosslinking of functionalized polyethylene glycol
JP2009518129A (en) 2005-12-06 2009-05-07 タイコ ヘルスケア グループ リミテッド パートナーシップ Bioabsorbable surgical composition
AU2006321856B2 (en) * 2005-12-08 2013-01-31 Covidien Lp Biocompatible surgical compositions
WO2007067806A2 (en) * 2005-12-08 2007-06-14 Tyco Healthcare Group Lp Biocompatible surgical compositons
CA2629932C (en) * 2005-12-08 2014-07-08 Tyco Healthcare Group Lp Viscosity-reduced sprayable compositions
CA2573472A1 (en) * 2006-01-23 2007-07-23 Tyco Healthcare Group Lp Biodegradable hemostatic compositions
EP2311505B1 (en) 2006-02-09 2013-11-06 BioMimetic Therapeutics, LLC Compositions and methods for treating bone
US20070191816A1 (en) * 2006-02-13 2007-08-16 Boston Scientific Scimed, Inc. Radio frequency induced drug elution
CA2637220C (en) 2006-02-22 2015-04-21 Tyco Healthcare Group Lp Biodegradable phosphoester polyamines
US8673019B2 (en) * 2006-04-13 2014-03-18 Warsaw Orthopedic, Inc. Use of anti-inflammatory compounds with allograft tissue implantation
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9642891B2 (en) 2006-06-30 2017-05-09 Biomimetic Therapeutics, Llc Compositions and methods for treating rotator cuff injuries
US7931651B2 (en) 2006-11-17 2011-04-26 Wake Lake University Health Sciences External fixation assembly and method of use
US8377016B2 (en) 2007-01-10 2013-02-19 Wake Forest University Health Sciences Apparatus and method for wound treatment employing periodic sub-atmospheric pressure
US8870871B2 (en) 2007-01-17 2014-10-28 University Of Massachusetts Lowell Biodegradable bone plates and bonding systems
GB2446653A (en) * 2007-02-16 2008-08-20 Inion Ltd Osteogenic compounds
EP2146794B1 (en) 2007-04-12 2016-10-19 Biomet Biologics, LLC Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
US20110123476A1 (en) * 2007-05-24 2011-05-26 Mbiya Kapiamba Adhesive Formulations
EP1997462A1 (en) * 2007-06-01 2008-12-03 Christophe Lesca Intraoral dressing
US9095391B2 (en) * 2007-06-11 2015-08-04 Aeolin Llc Osseointegration and biointegration coatings for bone screw implants
US7858835B2 (en) * 2007-06-27 2010-12-28 Tyco Healthcare Group Lp Foam control for synthetic adhesive/sealant
EP2160169A4 (en) 2007-06-29 2017-07-05 KCI Licensing, Inc. Activation of bone and cartilage formation
AU2013231068B2 (en) * 2007-06-29 2015-11-12 Kci Licensing Inc. Activation of bone and cartilage formation
WO2009003294A1 (en) 2007-07-03 2009-01-08 Synergy Biosurgical Ag Medical implant
PL2187818T3 (en) 2007-09-17 2014-04-30 Synergy Biosurgical Ag Medical implant
US9247973B2 (en) 2007-09-28 2016-02-02 DePuy Synthes Products, Inc. Anti-microbial implant
WO2009049058A1 (en) 2007-10-10 2009-04-16 Wake Forest University Health Sciences Devices and methods for treating spinal cord tissue
US8500947B2 (en) 2007-11-15 2013-08-06 Covidien Lp Speeding cure rate of bioadhesives
EP2217298B1 (en) 2007-11-21 2015-11-11 T.J. Smith & Nephew Limited Suction device and dressing
DK3000448T3 (en) 2007-11-21 2019-01-21 Smith & Nephew Wound dressing
GB0722820D0 (en) 2007-11-21 2008-01-02 Smith & Nephew Vacuum assisted wound dressing
GB0723875D0 (en) 2007-12-06 2008-01-16 Smith & Nephew Wound management
US11253399B2 (en) 2007-12-06 2022-02-22 Smith & Nephew Plc Wound filling apparatuses and methods
BRPI0906939A2 (en) 2008-01-09 2017-06-13 Univ Wake Forest Health Sciences apparatus and method for treating injured central nervous system tissue.
US20090181068A1 (en) * 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
GB0803564D0 (en) 2008-02-27 2008-04-02 Smith & Nephew Fluid collection
EP2567692B1 (en) 2008-02-27 2016-04-06 Biomet Biologics, LLC Use of a device for obtaining interleukin-1 receptor antagonist rich solutions
US8324292B2 (en) * 2008-02-29 2012-12-04 Ethicon, Inc. Medically acceptable formulation of a diisocyanate terminated macromer for use as an internal adhesive or sealant
EP2254991B1 (en) * 2008-02-29 2018-08-22 Biomet Manufacturing, LLC A system and process for separating a material
US8071663B2 (en) * 2008-02-29 2011-12-06 Ethicon, Inc. Medically acceptable formulation of a diisocyanate terminated macromer for use as an internal adhesive or sealant
WO2010009291A1 (en) * 2008-07-16 2010-01-21 Surmodics Pharmaceuticals, Inc. Process for preparing microparticles containing bioactive peptides
AU2009270695A1 (en) 2008-07-17 2010-01-21 Ap Pharma Methods for enhancing the stability of polyorthoesters and their formulations
US9289193B2 (en) 2008-07-18 2016-03-22 Wake Forest University Health Sciences Apparatus and method for cardiac tissue modulation by topical application of vacuum to minimize cell death and damage
US8551517B2 (en) * 2008-12-16 2013-10-08 Kimberly-Clark Worldwide, Inc. Substrates providing multiple releases of active agents
US9415197B2 (en) 2008-12-23 2016-08-16 Surmodics, Inc. Implantable suction cup composites and implants comprising same
US20100158978A1 (en) * 2008-12-23 2010-06-24 Peter Markland Bioactive spray coating compositions and methods of making and uses thereof
EP2223707B1 (en) * 2009-02-26 2014-04-09 New Dent AG Implant system and bone implant
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) * 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US20120045487A1 (en) * 2009-04-29 2012-02-23 The Regents Of The University Of Michigan Multiphasic microfibers for spatially guided cell growth
US9011800B2 (en) * 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
CA2779429C (en) 2009-11-30 2019-06-18 Synthes Usa, Llc Expandable implant
US9993441B2 (en) 2009-12-30 2018-06-12 Surmodics, Inc. Controlled release matrix barrier structure for subcutaneous medical devices
JP6144049B2 (en) 2010-02-22 2017-06-07 バイオミメティック セラピューティクス，リミテッド ライアビリティ カンパニー Platelet-derived growth factor compositions and methods for treating tendon disorders
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9061095B2 (en) 2010-04-27 2015-06-23 Smith & Nephew Plc Wound dressing and method of use
GB201011173D0 (en) 2010-07-02 2010-08-18 Smith & Nephew Provision of wound filler
GB201011552D0 (en) * 2010-07-09 2010-08-25 Smith & Nephew Adhesive and a method of delivery
WO2012030822A1 (en) 2010-08-30 2012-03-08 Surmodics Pharmaceuticals, Inc. Process for reducing moisture in a biodegradable implant device
US20140147472A1 (en) * 2010-09-28 2014-05-29 Medizn Technologies Ltd. Bioadhesive composition and device for repairing tissue damage
EP2643412B1 (en) 2010-11-25 2016-08-17 Smith & Nephew PLC Composition i-ii and products and uses thereof
GB201020005D0 (en) 2010-11-25 2011-01-12 Smith & Nephew Composition 1-1
US9592243B2 (en) 2011-04-25 2017-03-14 Warsaw Orthopedic, Inc. Medical devices and methods comprising an anabolic agent for treatment of an injury
US9511077B2 (en) 2011-04-25 2016-12-06 Warsaw Orthopedic, Inc. Medical devices and methods comprising an anabolic agent for wound healing
US20150159066A1 (en) 2011-11-25 2015-06-11 Smith & Nephew Plc Composition, apparatus, kit and method and uses thereof
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US20160120706A1 (en) 2013-03-15 2016-05-05 Smith & Nephew Plc Wound dressing sealant and use thereof
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
DE102013009737A1 (en) * 2013-06-11 2014-12-11 Alfons Erdmann Connection system for connecting a fluid line
US10130869B2 (en) 2016-01-22 2018-11-20 Hydra Management Llc Scratch-off games with variable reveal feature
CN113081391A (en) * 2017-03-22 2021-07-09 爱德华兹生命科学公司 Systems and methods for implanting and securing bioprosthetic devices to wet tissue
JP2019146747A (en) * 2018-02-27 2019-09-05 賀代 小久保 Method of embedding dental implant
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
KR102547679B1 (en) * 2023-02-07 2023-06-26 주식회사 티엠디랩 Shape-memory polymers with self-expandable and biofilm-reducing properties and use of the same as medical materials

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159293A1 (en) * 1984-04-02 1985-10-23 Battelle Memorial Institute Film-forming polymeric material for use in dressings, and its production
WO1990003768A1 (en) * 1988-10-03 1990-04-19 Southern Research Institute Biodegradable in-situ forming implants
WO1991001126A1 (en) * 1989-07-24 1991-02-07 Vipont Pharmaceutical Inc. Biodegradable system for regenerating the periodontium
WO1992000718A1 (en) * 1990-07-03 1992-01-23 Vipont Pharmaceutical, Inc. Intragingival delivery systems for treatment of periodontal disease
EP0537559A1 (en) * 1991-10-15 1993-04-21 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
EP0539751A1 (en) * 1991-10-28 1993-05-05 Atrix Laboratories, Inc. Biodegradable polymer composition
EP0560014A1 (en) * 1992-03-12 1993-09-15 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2155658A (en) * 1936-01-08 1939-04-25 Chemische Forschungs Gmbh Surgical and medical preparations
US3463158A (en) * 1963-10-31 1969-08-26 American Cyanamid Co Polyglycolic acid prosthetic devices
US3887699A (en) * 1969-03-24 1975-06-03 Seymour Yolles Biodegradable polymeric article for dispensing drugs
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3991766A (en) * 1973-05-31 1976-11-16 American Cyanamid Company Controlled release of medicaments using polymers from glycolic acid
US4076798A (en) * 1975-05-29 1978-02-28 American Cyanamid Company High molecular weight polyester resin, the method of making the same and the use thereof as a pharmaceutical composition
US4122129A (en) * 1976-06-01 1978-10-24 American Cyanamid Company Normally-solid, bioabsorbable, hydrolyzable, polymeric reaction product
US4105034A (en) * 1977-06-10 1978-08-08 Ethicon, Inc. Poly(alkylene oxalate) absorbable coating for sutures
US4181983A (en) * 1977-08-29 1980-01-08 Kulkarni R K Assimilable hydrophilic prosthesis
US4272518A (en) * 1979-07-10 1981-06-09 Moro Daniel G Plastic wound bandage
US4793336A (en) * 1981-03-25 1988-12-27 Wang Paul Y Wound coverings and processes for their preparation
US4631188A (en) * 1983-08-31 1986-12-23 S.K.Y. Polymers, Ltd. (Kingston Technologies) Injectable physiologically-acceptable polymeric composition
DD281908A7 (en) * 1984-10-23 1990-08-29 Jenapharm Veb METHOD AND DEVICE FOR PRODUCING HIGHLY ATMOSPHERABLE POLYACRYLATE ADHESIVE LAYERS
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
US4981696A (en) * 1986-12-22 1991-01-01 E. I. Du Pont De Nemours And Company Polylactide compositions
US4913903A (en) * 1987-02-04 1990-04-03 Alza Corporation Post-surgical applications for bioerodible polymers
US5013553A (en) * 1987-06-30 1991-05-07 Vipont Pharmaceutical, Inc. Drug delivery devices
GB8720440D0 (en) * 1987-08-28 1987-10-07 Smith & Nephew Ass Curable compositions
US5324520A (en) * 1988-12-19 1994-06-28 Vipont Pharmaceutical, Inc. Intragingival delivery systems for treatment of periodontal disease
EP0390481B1 (en) * 1989-03-23 1996-02-28 Sanyo Chemical Industries Ltd. Surgical adhesive sheet
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
JP2928892B2 (en) * 1990-11-27 1999-08-03 三洋化成工業株式会社 Surgical adhesive
US5266359A (en) * 1991-01-14 1993-11-30 Becton, Dickinson And Company Lubricative coating composition, article and assembly containing same and method thereof
US5154706A (en) * 1991-08-07 1992-10-13 Ndm Acquisition Corp. Wound dressing for deep wounds
US5276079A (en) * 1991-11-15 1994-01-04 Minnesota Mining And Manufacturing Company Pressure-sensitive poly(n-vinyl lactam) adhesive composition and method for producing and using same
US5461124A (en) * 1992-07-24 1995-10-24 Henkel Kommanditgesellschaft Auf Aktien Reactive systems and/or polymer composition for tissue contact with the living body

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159293A1 (en) * 1984-04-02 1985-10-23 Battelle Memorial Institute Film-forming polymeric material for use in dressings, and its production
WO1990003768A1 (en) * 1988-10-03 1990-04-19 Southern Research Institute Biodegradable in-situ forming implants
WO1991001126A1 (en) * 1989-07-24 1991-02-07 Vipont Pharmaceutical Inc. Biodegradable system for regenerating the periodontium
WO1992000718A1 (en) * 1990-07-03 1992-01-23 Vipont Pharmaceutical, Inc. Intragingival delivery systems for treatment of periodontal disease
EP0537559A1 (en) * 1991-10-15 1993-04-21 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
EP0539751A1 (en) * 1991-10-28 1993-05-05 Atrix Laboratories, Inc. Biodegradable polymer composition
EP0560014A1 (en) * 1992-03-12 1993-09-15 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9539332B2 (en) 2004-08-05 2017-01-10 Abbott Cardiovascular Systems Inc. Plasticizers for coating compositions
US9545377B2 (en) 2004-10-14 2017-01-17 Biomimetic Therapeutics, Llc Platelet-derived growth factor compositions and methods of use thereof
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
US9468707B2 (en) 2007-06-29 2016-10-18 Abbott Cardiovascular Systems Inc. Biodegradable triblock copolymers for implantable devices
US8870954B2 (en) 2008-09-09 2014-10-28 Biomimetic Therapeutics, Llc Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries

Also Published As

Publication number Publication date
DE69530919T2 (en) 2004-05-13
CA2187355C (en) 2009-10-13
US5707647A (en) 1998-01-13
CA2187355A1 (en) 1995-10-26
WO1995028124A2 (en) 1995-10-26
AU1999995A (en) 1995-11-10
JPH09511666A (en) 1997-11-25
EP0754064A1 (en) 1997-01-22
ATE241394T1 (en) 2003-06-15
DE69530919D1 (en) 2003-07-03
EP0754064B1 (en) 2003-05-28
US5717030A (en) 1998-02-10

Similar Documents

Publication Publication Date Title
AU1999995A (en) An adjunctive polymer system for use with medical device
AU5953398A (en) Port body for the administration of drugs
AU9486901A (en) Coated medical devices
MXPA03006825A (en) Coated vascular devices.
MXPA03003869A (en) Coated medical devices.
EP2196226A3 (en) Coated medical devices
WO2003040986A3 (en) Patient directed therapy management
AU1369297A (en) Medical implant
DE60124286D1 (en) COATED MEDICAL EQUIPMENT
EP0667131A3 (en) Percutaneous implantable endoprothesin in the body of a patient.
CA2235919A1 (en) Non-polymeric sustained release delivery system
AU5588896A (en) Implantable medical device
ES2167611T3 (en) GEL FORMULATIONS CONTAINING GROWTH FACTORS.
AU4114993A (en) Biocompatible, therapeutic, implantable device
AU2255195A (en) A medical article for implantation into the vascular system of a patient
WO2003077972A8 (en) Implantable drug delivery system
CA2198530A1 (en) Self-Expanding Stent Delivery System
AU2258292A (en) Implantable medical device with flexible hardware platform
AU4601500A (en) System for incorporating sonomicrometer functions into medical instruments and implantable biomedical devices
CA2030459A1 (en) Biodegradable ocular implants
MXPA03003354A (en) Coated medical devices for the treatment of vascular disease.
CA2350838A1 (en) Controlled release system for delivering therapeutic agents into the inner ear
WO2000018331A3 (en) Drug delivery systems
ATE302029T1 (en) COATED MEDICAL DEVICES AND METHODS OF STERILIZATION
AU3049489A (en) Crosslinked hydrophilic copolymer for medical and paramedical use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NL NO NZ PL PT RO RU SD SE SG SI SK TJ TT UA UZ VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NL NO NZ PL PT KE

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2187355

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1995913716

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1995913716

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 1995913716

Country of ref document: EP